Insider Transactions in Q1 2023 at Nu Skin Enterprises, Inc. (NUS)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,360
+20.75%
|
-
|
|
Mar 27
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.11%
|
$78,000
$39.29 P/Share
|
|
Mar 13
2023
|
Emma S. Battle Director |
BUY
Small Acquisition
|
Direct |
15
+0.19%
|
$600
$40.0 P/Share
|
|
Mar 09
2023
|
Steven Keith Hatchett Chief Product Officer |
SELL
Open market or private sale
|
Direct |
21,155
-26.6%
|
$825,045
$39.78 P/Share
|
|
Mar 09
2023
|
Steven Keith Hatchett Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,155
+21.01%
|
$634,650
$30.45 P/Share
|
|
Mar 08
2023
|
Edwina D Woodbury Director |
BUY
Grant, award, or other acquisition
|
Direct |
15
+0.09%
|
$585
$39.74 P/Share
|
|
Mar 02
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
25,000
-54.07%
|
$1,000,000
$40.77 P/Share
|
|
Mar 02
2023
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+18.61%
|
$750,000
$30.54 P/Share
|
|
Mar 02
2023
|
Mark H Lawrence Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,144
-31.39%
|
$1,045,760
$40.8 P/Share
|
|
Mar 02
2023
|
Mark H Lawrence Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,041
+17.8%
|
$541,230
$30.45 P/Share
|
|
Mar 01
2023
|
Steven Lund Exec. Chairman of the Board |
SELL
Bona fide gift
|
Indirect |
9,050
-7.38%
|
-
|
|
Mar 01
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
68,485
-76.33%
|
$2,739,400
$40.44 P/Share
|
|
Mar 01
2023
|
Joseph Y Chang Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,485
+43.29%
|
$2,054,550
$30.63 P/Share
|
|
Feb 28
2023
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.81%
|
$400,000
$40.68 P/Share
|
|
Feb 28
2023
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.3%
|
$300,000
$30.63 P/Share
|
|
Feb 27
2023
|
Ryan S Napierski President and CEO |
SELL
Open market or private sale
|
Direct |
21,513
-11.31%
|
$882,033
$41.38 P/Share
|
|
Feb 27
2023
|
Ryan S Napierski President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
21,513
+10.16%
|
$645,390
$30.63 P/Share
|
|
Feb 23
2023
|
James D Thomas Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,829
-13.63%
|
$115,989
$41.12 P/Share
|
|
Feb 22
2023
|
Emma S. Battle Director |
SELL
Open market or private sale
|
Direct |
987
-17.48%
|
$40,467
$41.7 P/Share
|
|
Feb 22
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.53%
|
$41,000
$41.42 P/Share
|
|
Feb 22
2023
|
Chayce David Clark EVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
18,090
+15.14%
|
-
|
|
Feb 22
2023
|
Steven Keith Hatchett Chief Product Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,251
+14.94%
|
-
|
|
Feb 22
2023
|
James D Thomas Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,330
+31.01%
|
-
|
|
Feb 22
2023
|
Mark H Lawrence Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,899
+23.37%
|
-
|
|
Feb 22
2023
|
Connie Mang Yee Tang Chief Global Growth Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,507
+23.36%
|
-
|
|
Feb 22
2023
|
Ryan S Napierski President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
53,064
+23.92%
|
-
|
|
Feb 15
2023
|
James D Thomas Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,295
-10.18%
|
$58,275
$45.38 P/Share
|
|
Feb 15
2023
|
Joseph Y Chang Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,981
-8.53%
|
$89,145
$45.38 P/Share
|
|
Feb 15
2023
|
Chayce David Clark EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,303
-1.54%
|
$58,635
$45.38 P/Share
|
|
Feb 15
2023
|
Steven Keith Hatchett Chief Product Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,314
-2.66%
|
$59,130
$45.38 P/Share
|
|
Feb 15
2023
|
Connie Mang Yee Tang Chief Global Growth Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
870
-2.75%
|
$39,150
$45.38 P/Share
|
|
Feb 15
2023
|
Mark H Lawrence Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,868
-5.95%
|
$129,060
$45.38 P/Share
|
|
Feb 15
2023
|
Ryan S Napierski President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,963
-5.68%
|
$313,335
$45.38 P/Share
|
|
Jan 23
2023
|
Andrew D Lipman Director |
SELL
Open market or private sale
|
Direct |
1,000
-1.51%
|
$42,000
$42.27 P/Share
|